Esophageal and Gastroesophageal Junction Carcinoma

Esophageal and Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,310 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 460
Recruiting: 254
Ph III recruiting: 40
Growth YoY: +36.1%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (120)

clinicaltrialsPublishedShowing 751–800 of 1,310 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02287129	Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction(MEMORI)	completed	Phase 2	75	Technical University of MunichOTHER	1	Nov 28, 2023	clinicaltrials
NCT04187352	A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma	completed	Phase 3	540	CStone PharmaceuticalsINDUSTRY	1	Nov 24, 2023	clinicaltrials